Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Hydroxyurea versus busulphan f...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Hydroxyurea versus busulphan for chronic myeloid leukaemia: an individual patient data meta-analysis of three randomized trials
Bibliographic Details
Main Authors:
Hehlmann, R
,
Heimpel, H
,
Hasford, J
,
Allan, N
,
Burnett, A
,
Shepherd, P
,
Oberg, G
,
Simonsson, B
,
Stromberg, U
,
Alison, R
,
Clarke, M
,
Evans, V
,
Godwin, J
,
MacKinnon, E
,
Richards, S
,
Trialist, C
Format:
Journal article
Published:
2000
Holdings
Description
Similar Items
Staff View
Similar Items
Severe cytopenias associated with the sequential use of busulphan and interferon-alpha in chronic myeloid leukaemia.
by: Shepherd, P, et al.
Published: (1994)
Thioguanine used in maintenance therapy of chronic myeloid leukaemia causes non-cirrhotic portal hypertension. Results from MRC CML. II. Trial comparing busulphan with busulphan and thioguanine.
by: Shepherd, P, et al.
Published: (1991)
Oesophageal varices associated with busulphan-thioguanine combination therapy for chronic myeloid leukaemia.
by: Key, N, et al.
Published: (1987)
Interferon-alpha therapy in chronic myeloid leukaemia is probably better than hydroxyurea alone.
by: Allan, N, et al.
Published: (1995)
Autologous stem cell transplantation in chronic myeloid leukaemia: A meta-analysis of six randomized trials
by: Smith, G, et al.
Published: (2007)